103 related articles for article (PubMed ID: 18312779)
1. Postprandial hyperglycemia: are all sulfonylureas created equal?
Kapoor JR
Am J Cardiol; 2008 Feb; 101(4):554-5. PubMed ID: 18312779
[No Abstract] [Full Text] [Related]
2. [Glinide(s), sulfonylurea(s)].
Arakawa M; Hirose T
Nihon Rinsho; 2006 Nov; 64(11):2107-12. PubMed ID: 17087304
[TBL] [Abstract][Full Text] [Related]
3. Drugs for type 2 diabetes.
Treat Guidel Med Lett; 2008 Jul; 6(71):47-54. PubMed ID: 18583949
[No Abstract] [Full Text] [Related]
4. [Antidiabetic Drugs and the Kidney].
Candido R
G Ital Nefrol; 2016 Malattie Metaboliche e Rene; 33(S68):. PubMed ID: 27960013
[No Abstract] [Full Text] [Related]
5. Diabetes under control: Understanding oral antidiabetic agents.
Longo R
Am J Nurs; 2010 Feb; 110(2):49-52. PubMed ID: 20107402
[No Abstract] [Full Text] [Related]
6. Glimepiride and serum adiponectin level in type 2 diabetic subjects: response to Nagasaka et al.
Yoshioka K; Yoshida T; Yoshikawa T
Diabetes Care; 2003 Dec; 26(12):3360-1; author reply 3361. PubMed ID: 14633838
[No Abstract] [Full Text] [Related]
7. [Fasting hyperglycemia and postprandial glucose peaks. Diabetes therapy mustact on 2 sides].
MMW Fortschr Med; 2003 Aug; 145(33-34):59. PubMed ID: 14526583
[No Abstract] [Full Text] [Related]
8. [Sulfonylureas and glinides].
Hirose T
Nihon Rinsho; 2006 Dec; 64 Suppl 9():646-53. PubMed ID: 17458297
[No Abstract] [Full Text] [Related]
9. [Sulfonylureas and glinides].
Kudo K; Hirose T
Nihon Rinsho; 2011 Jan; 69 Suppl 1():645-53. PubMed ID: 21766676
[No Abstract] [Full Text] [Related]
10. Should diabetic patients treated long-term with sulfonylureas be switched to nateglinide?
Sevinc A
Arch Intern Med; 2003 Jul; 163(14):1741. PubMed ID: 12885691
[No Abstract] [Full Text] [Related]
11. [New molecules].
Sternon J
J Pharm Belg; 2001; 56(5):105-10. PubMed ID: 11759148
[TBL] [Abstract][Full Text] [Related]
12. Current oral agents for type 2 diabetes. Many options, but which to choose when?
Ahmann AJ; Riddle MC
Postgrad Med; 2002 May; 111(5):32-4, 37-40, 43-6. PubMed ID: 12040862
[TBL] [Abstract][Full Text] [Related]
13. Current understanding regarding the role of repaglinide in post-prandial hyperglycemia.
Menon PS
J Assoc Physicians India; 2001 Jan; 49 Spec No():50-3. PubMed ID: 11235606
[No Abstract] [Full Text] [Related]
14. [Prandial glucose regulator and insulin secretagogue; glinide and its combination therapy].
Nakashima E
Nihon Rinsho; 2015 Mar; 73(3):416-23. PubMed ID: 25812367
[TBL] [Abstract][Full Text] [Related]
15. [New drugs].
Sternon J
Rev Med Brux; 2001 Sep; 22(4):A394-400. PubMed ID: 11680207
[TBL] [Abstract][Full Text] [Related]
16. Panel discussion on achieving glycemic control.
Buse JB; Einhorn D
Postgrad Med; 2001 Dec; 110(6 Suppl):20-5. PubMed ID: 19667581
[TBL] [Abstract][Full Text] [Related]
17. [Significance of insulin secretion pattern lectured by "glinides" in the treatment of postprandial hyperglycemia].
Hirose T
Nihon Rinsho; 2005 Dec; 63(12):2237-44. PubMed ID: 16363700
[TBL] [Abstract][Full Text] [Related]
18. Preventing the progressive nature of type 2 diabetes.
Cardiovasc J S Afr; 2002; 13(4):211-3. PubMed ID: 12402899
[No Abstract] [Full Text] [Related]
19. Modifications of glycemia and insulinemia in diabetics treated with glipizide (K 4024), a new sulfonylurea.
Fedele D; Tiengo A; Riva F; Muggeo M; Emanueli A; Crepaldi G
Arzneimittelforschung; 1972 Nov; 22(11):1885-8. PubMed ID: 4679060
[No Abstract] [Full Text] [Related]
20. [Pharmacological treatment of postprandial hyperglycemia in hypertensive patients with type 2 diabetes mellitus].
Yamada K
Nihon Rinsho; 2003 Jul; 61(7):1219-23. PubMed ID: 12877088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]